New lipids for RNA delivery

Learn more about how the mRNA and lipid nanoparticles team is developing novel lipids to create cost-effective RNA delivery systems.

The problem

Current ionisable lipid nanoparticle technologies for delivering RNA are limited by high costs and licensing challenges, hindering the development of mRNA-based vaccines and therapeutics.

Our solution

We will design, synthesize, and test novel ionisable lipids to create new formulations to deliver RNA therapeutics for a range of different applications.

The impact

Our project aims to make RNA delivery technology more cost-effective and versatile, enabling the development of more affordable and accessible RNA-based vaccines and therapeutics, which could have a significant impact on global health.

This project is funded by RNA Platform Fast Start.

Research team

Related story